

SCCM: PROPHY-VAP and Mailbag
Jan 30, 2024
Guest Professor Dahyot-Fizelier discusses the study on Ceftriaxone for preventing pneumonia in brain injury patients. Other topics include SCCM conference, intubation timing, and steroids in ARDS.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 2min
Comparing Critical Care Conferences and the Importance of Learning from Different Perspectives
01:36 • 14min
Misjudgment of Session Capacity and Frustrations with Conference Apps
15:31 • 10min
Understanding Inclusion Criteria and Prior Antibiotic Use
25:12 • 12min
Effectiveness of Single Dose of Ceftriaxone in Reducing Mortality
37:28 • 8min
Concrete Thinking and S-rage Explanation
45:51 • 2min
Heterogeneity in Severe Pneumonia and ARDS
47:37 • 7min